Liebert M, Wedemeyer G A, Stein J A, Washington R W, Flint A, Ren L Q, Grossman H B
Department of Surgery, University of Michigan, Ann Arbor 48109-0330.
Cancer Res. 1989 Dec 1;49(23):6720-6.
The reactivities of two anti-bladder cancer monoclonal antibodies, AN43 and BB369, were characterized. AN43 and BB369 reacted with a majority (greater than 50%) of bladder cancer tissue sections tested by immunoperoxidase staining. When tested against a panel of 27 normal human tissues, AN43 and BB369 reacted only with urothelium and stomach. AN43 and BB369 showed identical binding patterns and competed for binding on bladder cancer cells, suggesting that the two antibodies react with identical or spatially close epitopes. Bound BB369 antibody was rapidly shed from the surface of viable UM-UC-9 human bladder cancer cells. The antigen was found in spent tissue culture medium from the UM-UC-9 human bladder cancer cell line. AN43 and BB369 define a shed bladder tumor-associated antigen with limited distribution on normal tissues. The antigen is different from bladder tumor-associated antigens defined by other monoclonal antibodies and may be useful for the diagnosis and follow-up of patients with bladder cancer.
对两种抗膀胱癌单克隆抗体AN43和BB369的反应活性进行了表征。通过免疫过氧化物酶染色测试,AN43和BB369与大多数(超过50%)的膀胱癌组织切片发生反应。当针对一组27种正常人体组织进行测试时,AN43和BB369仅与尿路上皮和胃发生反应。AN43和BB369表现出相同的结合模式,并在膀胱癌细胞上竞争结合,这表明这两种抗体与相同或空间上接近的表位发生反应。结合的BB369抗体迅速从存活的UM-UC-9人膀胱癌细胞表面脱落。在UM-UC-9人膀胱癌细胞系的废弃组织培养基中发现了该抗原。AN43和BB369定义了一种脱落的膀胱肿瘤相关抗原,其在正常组织上的分布有限。该抗原不同于其他单克隆抗体所定义的膀胱肿瘤相关抗原,可能对膀胱癌患者的诊断和随访有用。